Announced the launch of the first vaccine on the international market next September </p><div> <p>Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), said that the Russian vaccine to treat the Coronavirus (Covid-19) is now officially ready and registered by the country's Ministry of Health, becoming the first vaccine on the international market.
With regard to a Saudi partnership in the production of the Corona virus vaccine and the bilateral cooperation project with the establishment of the largest vaccine factory, Dmitriev said, “Asharq Al-Awsat”: “Saudi Arabia is our main commercial partner and we discussed the joint development of all the main elements of our strategy to combat (Covid-19) with our Saudi partners. ».
“The third phase of clinical trials, involving more than 2000 people, will begin in Russia, Saudi Arabia, the UAE, Brazil and Mexico, after the official registration,” he said. “It is expected that mass production of the vaccine will start in September 2020. The vaccine will cost about $ 20.”
He added that the first two phases of clinical trials have ended, and their results will be published this month, in line with international requirements. These documents will provide detailed information about the vaccine, including the exact levels of the antibodies as shown in many third-party tests.
According to Dmitrieve, the main types of vaccines include vector-based viral vaccines, virus-based vaccines, DNA-based vaccines and protein-based vaccines.
Regarding Russia’s plan to export the vaccine to partner countries, Dmitriev said: “The fund sees strong global interest in the vaccine and plans to start mass production in other countries in partnership with local sovereign wealth funds.”
According to Dmitriev, the plan aims to increase vaccine production to 200 million doses by the end of 2020, including 30 million doses in Russia, as at least 50 countries have expressed interest in obtaining the vaccine, including Saudi Arabia, the UAE, Indonesia, the Philippines, Brazil, Mexico and India, and there are requests Other.